1. Home
  2. RPAY vs TNXP Comparison

RPAY vs TNXP Comparison

Compare RPAY & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repay Holdings Corporation

RPAY

Repay Holdings Corporation

HOLD

Current Price

$3.86

Market Cap

223.5M

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.38

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RPAY
TNXP
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.5M
198.6M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
RPAY
TNXP
Price
$3.86
$13.38
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$5.53
N/A
AVG Volume (30 Days)
2.2M
440.0K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.75
EPS
N/A
N/A
Revenue
$309,261,000.00
$13,107,000.00
Revenue This Year
$12.54
$558.11
Revenue Next Year
$4.66
$38.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.85
52 Week Low
$2.30
$11.60
52 Week High
$5.90
$69.65

Technical Indicators

Market Signals
Indicator
RPAY
TNXP
Relative Strength Index (RSI) 66.97 46.32
Support Level $3.35 $13.32
Resistance Level $5.23 $20.36
Average True Range (ATR) 0.24 0.84
MACD 0.14 0.08
Stochastic Oscillator 78.90 50.64

Price Performance

Historical Comparison
RPAY
TNXP

About RPAY Repay Holdings Corporation

Repay Holdings Corp is a payments technology company. It provides integrated payment processing solutions to industry-oriented vertical markets in which businesses or other organizations have specific transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments. The company generates majority of its revenue from Consumer Payments segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: